Nourish raises $100M Series C to pair dietitians with GLP-1 prescriptions and behavior change

Nourish raises $100M Series C

Nourish, which pairs registered dietitians with virtual medical care and GLP-1 medication management, has closed a $100M Series C. Aidan Dewar, co-founder and CEO, says the capital will go toward AI development, expanding the company's 10,000-strong dietitian network, and deepening insurance-covered care.

“Nourish is a dietitian-led metabolic clinic. We pair the largest network of registered dietitians in the country — over 10,000 dietitians — with virtual medical care. We raised a 100 million Series C. The big part of the round was to invest in AI as the 24/7 behavior change agent as part of the equation.”

The core bet

The pitch is that GLP-1 medications alone produce unsustainable outcomes. Without behavior change, patients rebound on weight and fall off medication, which is bad for the patient and bad for the health system that paid for the drugs. Nourish's model pairs medication prescribing and management with dietitian-led lifestyle coaching, all covered by insurance rather than out-of-pocket.

Dietitian is a protected term requiring a master's degree and supervised clinical hours. Nutritionist is not. That distinction matters because only registered dietitians can bill insurance, which is central to how Nourish frames its access argument.

GLP-1 market positioning

Nourish works exclusively with name-brand medications through health plan partnerships and does not compound. Dewar views the compounding and cash-pay market as a short-term workaround for the access and cost constraints of the last few years, not a durable business model. As GLP-1s move toward generic pricing over time, he argues the value shifts to wraparound care — integrated dietitian support, virtual medicine, and AI as a 24/7 behavior change layer — rather than the drug itself.

Meal delivery and vertical integration

Nourish has had inbound interest from meal delivery companies but hasn't prioritized partnerships yet. Dewar says the long-term logic is clear — removing barriers to acting on dietary recommendations, including the ability to "prescribe" food the way you prescribe medication — but it isn't on the near-term roadmap. He notes some health plans are exploring reimbursement for food as part of care, which could make the economics more tractable eventually.